HOME >> BIOLOGY >> NEWS
Study in Royal Society journal on possible genetic factors in social responsiblity

Proceedings of The Royal Society B: Biological Sciences

Geographic potential of Argentine ants (Linepithema humile Mayr) in the face of global climate change by Dr N Roura-Pascual, Dr AV Suarez, Dr C Gmez, Dr P Pons, Dr Y Touyama, Dr AL Wild and Dr AT Peterson

We examined the potential worldwide distribution of the Argentine ant (Linepithema humile) based on current climate models and also in the face of projected future climate change. Native to South America, Argentine ants have invaded broad areas around the world. Our results suggest that Argentine ants still have the potential to spread into areas not currently known to be occupied, particularly in regions of Africa and Asia. Higher latitudes appear to become more suitable for the Argentine ant under global climate change scenarios. Because invasion processes have the potential to alter global biodiversity considerably, this improved knowledge of the potential geography of the Argentine ant should be considered in preventive efforts.
Contact: Dr Nria Roura-Pascual, Departament de Cincies Ambientals, Universitat de Girona, Facultat de Cincies, GIRONA, 17071, Spain

Genetic and environmental contributions to pro-social attitudes: a twin study of social responsibility by Dr JP Rushton

A new study surprisingly shows genes, more than home environment, shape social responsibility attitudes. 174 pairs of identical twins and 148 pairs of non-identical twins from the University of London Twin Register rated themselves on 22 social attitudes such as "I am a person people can count on" and "It is important to finish anything you have started." Identical twins were almost twice as similar as non-identical twins. Genes determined 42%; home environment, 23%; and the non-home environment, the remainder of the variance. The ratings predict real life behaviour such as voting and helping others, implying these too have a genetic component.
Contact: Dr John Ru
'"/>

Contact: Tim Watson
tim.watson@royalsoc.ac.uk
44-207-451-2508
Royal Society
29-Nov-2004


Page: 1 2 3 4 5 6 7

Related biology news :

1. Study begins to reveal clues to the cause and progression of sepsis
2. Study finds gender differences in renal and other genes contributing to blood pressure
3. Study suggests estrogen deficiency can lead to obesity-induced high blood pressure after menopause
4. Study: Sticking to the sand might not be such good, clean fun for beachgoers
5. Study points to new way to predict death risk from torn aorta
6. Study identifies new gene therapy tools for inherited blindness
7. Study finds contaminated water reaching Floridas offshore keys
8. Study sheds light on why humans walk on two legs
9. Study explains how pathogens evolve to escape detection
10. Study finds hereditary link to premenstrual depression
11. Study identifies energy efficiency as reason for evolution of upright walking

Post Your Comments:
(Date:7/8/2015)... DIEGO , July 8, 2015  Trovagene, ... cell-free molecular diagnostics, today announced the launch of ... the Company,s Precision Cancer Monitoring℠ (PCM) technology for ... receiving one or a combination of the novel ... Opdivo® (nivolumab), a PD-1 inhibitor. The 50-patient study ...
(Date:7/7/2015)... -- Research and Markets ( ... "Capacitive Fingerprint Sensors Patent Landscape" report ... fingerprint sensing technology is the most reliable and ... developed. This patent landscape focuses on fingerprint sensors ... of capacitive fingerprint sensors is closely linked to ...
(Date:7/7/2015)... 7, 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... mobile commerce market announces a revised version of one of its ... will air on CNBC in New York , ... and San Francisco metro areas.    ... Wocket,s ability to replace all the cards in your wallet and ...
Breaking Biology News(10 mins):Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4Worldwide Capacitive Fingerprint Sensors Patent Landscape Market Report 2015-2020 - Main IP Holders include Seiko Epson, AuthenTec, Sony and STMicroelectronics 2Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 2Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 3
(Date:7/29/2015)... , ... July 29, 2015 , ... The third Medical ... combination products , in particular, drug/device combinations. The current system received a score ... Initiative for Patient Centered Innovation (iPCI) of Fairleigh Dickinson University’s ( FDU ...
(Date:7/29/2015)... , July 29, 2015 /PRNewswire/ - Aeterna Zentaris Inc. ... it has selected an optimized Erk inhibitor molecule ... the development of a new class of potential ... represents a prime target for therapeutic intervention in ... and survival benefits for B-Raf and Mek inhibitors. ...
(Date:7/29/2015)... ... July 29, 2015 , ... CSSi ... Silicon Valley-based CRO specializing in Clinical Trial Management. CSSi LifeSciences is specialized in ... core expertise of PRC Clinical is focused on Clinical Trial Management, Clinical Site ...
(Date:7/29/2015)... TX (PRWEB) , ... July 29, 2015 , ... Costello ... new levee system to protect the Orange County, Texas area from future storm ... multi-firm design team in determining several potential levee alignment alternatives for providing protection, Costello ...
Breaking Biology Technology:Third Medical Innovation Impact Index Issued by Fairleigh Dickinson University’s Initiative for Patient-Centered Innovation (iPCI) 2Third Medical Innovation Impact Index Issued by Fairleigh Dickinson University’s Initiative for Patient-Centered Innovation (iPCI) 3Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 3CSSi LifeSciences And PRC Clinical Join Forces To Offer Extended Clinical Trial Services 2CSSi LifeSciences And PRC Clinical Join Forces To Offer Extended Clinical Trial Services 3Preventing Storm Surge Flooding in Houston 2
Cached News: